APA (7th ed.) Citation

Congyang Ding, Yajing Li, Xiao Li, Lu Meng, Ran Fu, Xiaonan Wang, . . . Zhanjun Dong. (2022). QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Congyang Ding, Yajing Li, Xiao Li, Lu Meng, Ran Fu, Xiaonan Wang, Ying Li, Yinling Ma, and Zhanjun Dong. QiShenYiQi Pills, a Chinese Patent Medicine, Increase Bioavailability of Atorvastatin by Inhibiting Mrp2 Expression in Rats. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Congyang Ding, et al. QiShenYiQi Pills, a Chinese Patent Medicine, Increase Bioavailability of Atorvastatin by Inhibiting Mrp2 Expression in Rats. Taylor & Francis Group, 2022.